2Dunham CM. Clinical impact of continuous renal replacement therapy on multiple organ failure. World J Surg, 2001, 25: 669-676.
3Levi M, Ten Cate Hugo. Disseminated intravascular coagulation. N Eng J Med, 1999, 341: 586-592.
4Le Gall J R, Lemeshow S, Saulnier F. A new simplified acute physiology score (SAPS Ⅱ) based on a European/North American multicenterstudy. JAMA, 1993, 270: 2957-2963.
4Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：828
5Camus C,Lavoué S,Gacouin A,et al.Liver transplantation avoided in patients with fulminant hepatic failure who received albumin dialysis with the molecular adsorbent reeirculating system while on the waiting list:impact of the duration of therapy[J].Ther Apher Dial,2009,13(6):549-555.
6Chiu A,Chan L M,Fan S T.Molecular adsorbent recirculating system treatment for patients with liver failure:the Hong Kong experience[J].Liver lnt,2006,26(6):695-702.
8Garguilo J M,Davis B A,Buddie M,et al.Fibrinogen adsorption onto microwave plasma chemical vapor deposited diamond films[J].Diamond and Related Aterials,2004,13(4):595-599.
9Yang W S,Tan H K,Lui H F,et al.albumin dialysis in critically Ⅲ Patients:use versus omission of intradialytic heparin[J].Artif Organs,2008,32(5):411-416.
10Bachlil E,Schuepbachl R,Maggiorini M,et al.artificial liver support with the molecular adsorbent recirculating system:activation of coagulation and bleeding complications[J]:Liver International,2007,27(4):475-484.
